Amanda I Phipps1,2, Jamaica R Robinson1,2, Peter T Campbell3, Aung Ko Win4, Jane C Figueiredo5, Noralane M Lindor6, Polly A Newcomb1,2. 1. Epidemiology Department, University of Washington, Seattle, Washington. 2. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 3. American Cancer Society, Atlanta, Georgia. 4. Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. 5. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. 6. Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona.
Abstract
BACKGROUND: Although previous studies have noted an increased risk of colorectal cancer (CRC) among moderate to heavy alcohol consumers in comparison with nondrinkers, the relation between alcohol consumption and CRC survival remains unclear. METHODS: Cases of incident invasive CRC diagnosed between 1997 and 2007 were identified via population-based cancer registries at 4 study sites in the Colon Cancer Family Registry. Study participants completed a risk-factor questionnaire on prediagnostic behaviors, including wine, beer, and liquor consumption, at the baseline. Prospective follow-up for survival was conducted for 4966 CRC cases. Cox regression was used to compare nondrinkers with individuals who consumed, on average, 1 or more servings of alcohol per day in the years preceding their CRC diagnosis with respect to overall and disease-specific survival. Separate analyses by beverage type, stratified by patient and tumor attributes, were also performed. All models were adjusted for the age at diagnosis, sex, study site, year of diagnosis, smoking history, body mass index, and education. RESULTS: Prediagnostic beer and liquor consumption was not associated with CRC survival; however, higher levels of wine consumption were modestly associated with a better prognosis overall (CRC-specific hazard ratio [HR], 0.70, 95% confidence interval [CI], 0.48-1.03; overall HR, 0.70; 95% CI, 0.53-0.94). Similar patterns were noted in stratified analyses. CONCLUSIONS: These findings suggest that prediagnostic wine consumption is modestly associated with more favorable survival after CRC. Cancer 2017;123:1035-43.
BACKGROUND: Although previous studies have noted an increased risk of colorectal cancer (CRC) among moderate to heavy alcohol consumers in comparison with nondrinkers, the relation between alcohol consumption and CRC survival remains unclear. METHODS: Cases of incident invasive CRC diagnosed between 1997 and 2007 were identified via population-based cancer registries at 4 study sites in the Colon Cancer Family Registry. Study participants completed a risk-factor questionnaire on prediagnostic behaviors, including wine, beer, and liquor consumption, at the baseline. Prospective follow-up for survival was conducted for 4966 CRC cases. Cox regression was used to compare nondrinkers with individuals who consumed, on average, 1 or more servings of alcohol per day in the years preceding their CRC diagnosis with respect to overall and disease-specific survival. Separate analyses by beverage type, stratified by patient and tumor attributes, were also performed. All models were adjusted for the age at diagnosis, sex, study site, year of diagnosis, smoking history, body mass index, and education. RESULTS: Prediagnostic beer and liquor consumption was not associated with CRC survival; however, higher levels of wine consumption were modestly associated with a better prognosis overall (CRC-specific hazard ratio [HR], 0.70, 95% confidence interval [CI], 0.48-1.03; overall HR, 0.70; 95% CI, 0.53-0.94). Similar patterns were noted in stratified analyses. CONCLUSIONS: These findings suggest that prediagnostic wine consumption is modestly associated with more favorable survival after CRC. Cancer 2017;123:1035-43.
Authors: Sagar A Patel; Yu-Hui Chen; Jason L Hornick; Paul Catalano; Jonathan A Nowak; Lawrence R Zukerberg; Ronald Bleday; Paul C Shellito; Theodore S Hong; Harvey J Mamon Journal: Dis Colon Rectum Date: 2014-04 Impact factor: 4.585
Authors: Marilyn L Kwan; Lawrence H Kushi; Erin Weltzien; Emily K Tam; Adrienne Castillo; Carol Sweeney; Bette J Caan Journal: J Clin Oncol Date: 2010-08-30 Impact factor: 44.544
Authors: Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-11-02 Impact factor: 4.254
Authors: Amanda I Phipps; Qian Shi; Paul J Limburg; Garth D Nelson; Daniel J Sargent; Frank A Sinicrope; Emily Chan; Sharlene Gill; Richard M Goldberg; Morton Kahlenberg; Suresh Nair; Anthony F Shields; Polly A Newcomb; Steven R Alberts Journal: Int J Cancer Date: 2016-05-09 Impact factor: 7.396
Authors: Colleen Pelser; Hannah Arem; Ruth M Pfeiffer; Joanne W Elena; Catherine M Alfano; Albert R Hollenbeck; Yikyung Park Journal: Cancer Date: 2014-03-03 Impact factor: 6.860
Authors: Jonathan M Kocarnik; Xinwei Hua; Sheetal Hardikar; Jamaica Robinson; Noralane M Lindor; Aung Ko Win; John L Hopper; Jane C Figueiredo; John D Potter; Peter T Campbell; Steven Gallinger; Michelle Cotterchio; Scott V Adams; Stacey A Cohen; Amanda I Phipps; Polly A Newcomb Journal: Cancer Date: 2017-08-25 Impact factor: 6.860
Authors: Amanda I Phipps; Qian Shi; Tyler J Zemla; Efrat Dotan; Sharlene Gill; Richard M Goldberg; Sheetal Hardikar; Balkrishna Jahagirdar; Paul J Limburg; Polly A Newcomb; Anthony Shields; Frank A Sinicrope; Daniel J Sargent; Steven R Alberts Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-03-21 Impact factor: 4.254
Authors: Yang Hu; Ming Ding; Chen Yuan; Kana Wu; Stephanie A Smith-Warner; Frank B Hu; Andrew T Chan; Jeffrey A Meyerhardt; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Mingyang Song Journal: Gastroenterology Date: 2017-11-20 Impact factor: 22.682
Authors: Lakkhina Troeung; Nita Sodhi-Berry; Angelita Martini; Eva Malacova; Hooi Ee; Peter O'Leary; Iris Lansdorp-Vogelaar; David B Preen Journal: Front Public Health Date: 2017-07-24